Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1438Pancreatic Neoplasms 862Carcinoma, Hepatocellular 745Stomach Neoplasms 650Colonic Neoplasms 448Rectal Neoplasms 406Esophageal Neoplasms 400Breast Neoplasms 332Carcinoma, Non-Small-Cell Lung 328Neoplasms 307Liver Neoplasms 283Cholangiocarcinoma 244Ovarian Neoplasms 243Lung Neoplasms 239Neoplasm Metastasis 237Gastrointestinal Neoplasms 219Melanoma 186Esophageal Squamous Cell Carcinoma 167Prostatic Neoplasms 166Biliary Tract Neoplasms 161Endometrial Neoplasms 143Uterine Cervical Neoplasms 130Squamous Cell Carcinoma of Head and Neck 129Head and Neck Neoplasms 114Carcinoma, Renal Cell 114Sarcoma 101Urinary Bladder Neoplasms 97Adenocarcinoma Of Esophagus 90Triple Negative Breast Neoplasms 87Anus Neoplasms 83

Interventions

Radiotherapy, Image-Guided 1Catheter Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Liver Neoplasm × Gastrointestinal × 1 year × Clear all
NCT04083378 2026-03-23

Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
107 enrolled 14 charts
Gastrointestinal

Malignant Liver Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡